1-4 of 4
Deng Pan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selinexor in combination with venetoclax and azacitidine for newly diagnosed (ND) unfit Acute Myeloid Leukemia (AML): A multicenter, open-label prospective study

Free
Ligen Liu, Li Yang, Fangli Chen, Li Chang, Limin Zhao, Xiang Zhou, Chunrong Ying, Yingting Lu, Hong Liang, Yuansong Bai, Wenzhong Wu, Xiaojing Yan, Jinhai Ren, Si Li, Yang Yu, Laigen Tong, Deng Pan
Journal: Blood
Blood (2025) 146 (Supplement 1): 1685.
https://doi.org/10.1182/blood-2025-1685
Published: 2025
Journal Articles

The Efficacy and Survival Analysis of Fit-AML Patients Treated with Venetoclax Combined with Hypomethylating Agents (VEN-HMAs)

Free
Ludan Zhang, Jingchen Sui, Pingping Wang, Deng Pan, Xiaojing Yan
Journal: Blood
Blood (2024) 144 (Supplement 1): 5985.
https://doi.org/10.1182/blood-2024-209635
Published: 2024
Journal Articles

Early Bone Marrow Evaluation of Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients

Free
Ludan Zhang, Pingping Wang, Deng Pan, Xiaojing Yan
Journal: Blood
Blood (2024) 144 (Supplement 1): 5984.
https://doi.org/10.1182/blood-2024-209559
Published: 2024
Journal Articles

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Free
Li Yang, Fangli Chen, Hong Liang, Yunsong Bai, Wenzhong Wu, Xiaojing Yan, Jinhai Ren, Si Li, Yang Yu, Laigen Tong, Deng Pan, Ligen Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 55.
https://doi.org/10.1182/blood-2023-184581
Published: 2023